RxSight(RXST)
ALISO VIEJO, CABiotechnology
Focus: RxSight is a public ophthalmic medical device company specializing in Light Adjustable Intraocular Lenses (LALs) for cataract and aphakia correction. The company operates as a focused single-technology player in a niche but growing segment of ophthalmology.
Profile data last refreshed 13h ago · AI intelligence enriched 1mo ago
Funding Stage
PUBLIC
Open Jobs
42+38 this month
Hot — 49 jobs added in 30d
Net +38 (49 new, 11 removed). Aggressive expansion phase.
Should You Work at RxSight?
AI assessmentRxSight is a high-growth, venture-backed public company with strong revenue momentum but fragile cash position—suitable for risk-tolerant professionals seeking early-stage scaling experience in a focused ophthalmology device business.
Why Work Here
- Rapidly scaling revenue ($89M in FY2025 vs $49M in FY2024, +82% YoY growth) indicates product traction and market acceptance of a differentiated technology.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
9 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$89M
Pipeline & Clinical Trials
Light Adjustable lens
Aphakia CataractClinical Trials (1)
NCT07347379Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
N/AHelp build intelligence for RxSight
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.